bone marrow aspirations for Sensitized Post Kidney Transplant Recipients

Phase-Based Progress Estimates
1
Effectiveness
1
Safety
Sensitized Post Kidney Transplant Recipientsbone marrow aspirations - Procedure
Eligibility
18 - 99
All Sexes
What conditions do you have?
Select

Study Summary

This trial is testing whether two different tests can show why patients who have had a kidney transplant and have developed antibodies against their donor are at a greater risk for their transplanted organ being rejected.

Treatment Effectiveness

Study Objectives

1 Primary · 0 Secondary · Reporting Duration: Post bone marrow collection

Post bone marrow collection
To determine the variability of the AlloElispot and Allospecificities assay.

Trial Safety

Trial Design

1 Treatment Group

Sensitized Renal Allograft Recipients
1 of 1

Experimental Treatment

80 Total Participants · 1 Treatment Group

Primary Treatment: bone marrow aspirations · No Placebo Group · N/A

Sensitized Renal Allograft Recipients
Procedure
Experimental Group · 1 Intervention: bone marrow aspirations · Intervention Types: Procedure

Trial Logistics

Trial Timeline

Screening: ~3 weeks
Treatment: Varies
Reporting: post bone marrow collection

Who is running the clinical trial?

Mark StegallLead Sponsor
3 Previous Clinical Trials
1,235 Total Patients Enrolled
Mayo ClinicLead Sponsor
2,922 Previous Clinical Trials
3,517,073 Total Patients Enrolled
Mark Stegall, MDPrincipal Investigator - Mayo Clinic
Mayo Clinic Hospital-Rochester Saint Marys Campus
Columbia University College Of Physicians And Surgeons (Medical School)
University Of Wi Hosp & Cli (Residency)
4 Previous Clinical Trials
310 Total Patients Enrolled

Eligibility Criteria

Age 18 - 99 · All Participants · 3 Total Inclusion Criteria

Mark “Yes” if the following statements are true for you: